NTUS Key Statistics, Chart & Performance
The current stock price of NTUS is 32.96 USD. In the past month the price increased by 2.07%. In the past year, price increased by 32.69%.
NTUS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About NTUS
Company Profile
Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.
Company Info
NATUS MEDICAL INC
3150 Pleasant View Road
Middleton WISCONSIN 94566 US
CEO: Jonathan A. Kennedy
Employees: 1400
Phone: 16088298500.0
NATUS MEDICAL INC / NTUS FAQ
What does NTUS do?
Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.
What is the stock price of NATUS MEDICAL INC today?
The current stock price of NTUS is 32.96 USD. The price increased by 0.09% in the last trading session.
Does NATUS MEDICAL INC pay dividends?
NTUS does not pay a dividend.
How is the ChartMill rating for NATUS MEDICAL INC?
NTUS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Should I buy NTUS stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NTUS.
What is the market capitalization of NTUS stock?
NATUS MEDICAL INC (NTUS) has a market capitalization of 1.14B USD. This makes NTUS a Small Cap stock.
What is the next earnings date for NTUS stock?
NATUS MEDICAL INC (NTUS) will report earnings on 2022-08-04, after the market close.
NTUS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NTUS. When comparing the yearly performance of all stocks, NTUS is one of the better performing stocks in the market, outperforming 93.25% of all stocks.
NTUS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NTUS. NTUS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
NTUS Financial Highlights
Over the last trailing twelve months NTUS reported a non-GAAP Earnings per Share(EPS) of 1.26. The EPS increased by 147.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.65% | ||
| ROA | 2.23% | ||
| ROE | 2.94% | ||
| Debt/Equity | 0 |
NTUS Forecast & Estimates
For the next year, analysts expect an EPS growth of 22.4% and a revenue growth 5.1% for NTUS